Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6T4X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,757
Award facts
- Contract value 100% obligated
- $13,757.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,757.09 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on December 1, 2025, with completion expected by December 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support platform for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive federal contract portfolio supplying medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal procurement history demonstrates consistent performance in delivering brand-name and generic pharmaceuticals across multiple therapeutic domains, including specialty medications and diabetes treatments, through competitively awarded delivery orders with firm fixed pricing. This award for Zepbound, a diabetes medication, exemplifies AmerisourceBergen's role as a critical vendor supporting military and veteran healthcare supply chains.
Quick answers
Who was awarded contract SPE2DR26F6T4X?
SPE2DR26F6T4X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F6T4X worth?
The government has obligated $13,757 on SPE2DR26F6T4X.
Is contract SPE2DR26F6T4X an order under another contract?
Yes. SPE2DR26F6T4X is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6T4X competed?
The extent of competition for SPE2DR26F6T4X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award